Facilities

Too Much Guesswork in Process Development?

By working with Dowpharma^SM, you can eliminate the guesswork in process development. Our San Diego biotechnology center uses cutting edge technology to diagnose problems with the expression of your recombinant protein or peptide and design a robust solution.

Capabilities at the site include:

Molecular biology, including state-of-the-art genomics, bioinformatics and in silico metabolic modeling
Comprehensive protein characterization capability
26 networked, computer-controlled microbial fermentors up to 1,500 liter scale
Full range of primary recovery and purification assets
Analytical methods
Comprehensive protein and peptide characterization capability

See our San Diego Asset Sheet (128KB PDF).

For more information about our biotechnology center, contact us.

In order to view some information you may need to download Adobe Reader.

^SMService mark of The Dow Chemical Company

	Biopharmaceuticals & Peptides
Capabilities and Services Molecular Biology Expression Technologies Pfēnex Expression Technology Fermentation Process Development Purification Process Development Analytical Development Pilot Manufacturing cGMP Manufacturing Project Lifecycle Timeline PEGylation Why PEGs? Chemistry Analytical Why Dowpharma? Dowpharma PEGs Ordering PEGs Order Summary Checkout Thank You Events Calendar Facilities Literature and Resources News Center Dow Announces Price Increases of its Epoxy Novolac Resins In Asia Pacific, Europe, Middle East, Africa, India and Pakistan DowpharmaSM Announces Multi-Product License Agreement with Merck Dowpharma<sup>SM</sup> Signs Fourth Collaboration Agreement In First Quarter of 2006 for <i>Pf</i>ēnex Expression Technology™ DOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin VGX Pharmaceuticals and Dowpharma<sup>SM</sup> Sign Research and Development Agreement for VGX’s Lead Cancer Compound Viventia Biotech and Dowpharma<sup>SM</sup> Announce a Multi-Product Commercial License Agreement using <i>Pf</i>ēnex Expression Technology™ from Dowpharma DOR BioPharma and Dowpharma<sup>SM</sup> Complete Feasibility Study for Production of BT-VACC™, DOR’s Recombinant Botulinum Vaccine DOR BioPharma and Dowpharma Enter into a Joint Development Agreement for BT-VACC, DOR’s Oral Botulinum Toxin Vaccine Dowpharma<sup>SM</sup> Announces Commercial License Agreement for <i>Pf</i><script>document.write(unescape('%u0113'));</script>nex Expression Technology™ with Iomai Corporation <i>Smithsonian National Museum of American History</i> - Dow Donates DNA Fermenter to National Museum of American History Cambrex Named First Biopharmaceutical Manufacturing Partner for <i>Pf</i>ēnex Expression Technology™ from Dowpharma<sup>SM</sup> Dowpharma Relaunches Web Site, Will Make Donation to UNICEF Dowpharma<sup>SM</sup> Announces Agreement with Pfizer Inc using <i>Pf</i><script>document.write(unescape('%u0113'));</script>nex Expression Technology<sup>TM</sup> and Dow Solvent Extraction Tech. Dowpharma Sharpens Focus on New Expression Systems; Smithfield Facility Will be Closed Dowpharma Consolidates Biopharmaceutical Process Development to San Diego Dowpharma Announces Biologics Peptide Manufacture Dow Expands Presence in Pharmaceutical Market, Uniting Existing Offers Under Dowpharma Portfolio Dowpharma Introduces Next Generation Microbial Expression System for Production of Biotherapeutics Events Calendar Contact Us PEGylation	Facilities Too Much Guesswork in Process Development? By working with Dowpharma^SM, you can eliminate the guesswork in process development. Our San Diego biotechnology center uses cutting edge technology to diagnose problems with the expression of your recombinant protein or peptide and design a robust solution. Capabilities at the site include: Molecular biology, including state-of-the-art genomics, bioinformatics and in silico metabolic modeling Comprehensive protein characterization capability 26 networked, computer-controlled microbial fermentors up to 1,500 liter scale Full range of primary recovery and purification assets Analytical methods Comprehensive protein and peptide characterization capability See our San Diego Asset Sheet (128KB PDF). For more information about our biotechnology center, contact us. In order to view some information you may need to download Adobe Reader. ^SMService mark of The Dow Chemical Company
	Biopharmaceuticals, Peptides & PEGylation Dow Home Privacy Statement Internet Disclaimer Accessibility Statement Site Map Copyright © The Dow Chemical Company (1995-2008). All Rights Reserved.

Biopharmaceuticals & Peptides

Facilities